Undifferentiated Pleomorphic Sarcoma (UPS), from the CureRays guide library.

Undifferentiated pleomorphic sarcoma is one of the most common soft-tissue sarcomas of adults, usually a deep mass in an arm or leg; it is treated with limb-sparing surgery combined with radiation, which works microscopically beyond the tumor's edge to make removal safer and lower the chance of recurrence.

What it is.

Undifferentiated pleomorphic sarcoma (UPS) is one of the most common soft-tissue sarcomas in adults. A sarcoma is a cancer that arises in the body's connective tissues — muscle, fat, fibrous tissue, and the like — rather than in an organ lining. 'Undifferentiated' means the tumor cells are so abnormal that they no longer resemble any specific normal tissue, and 'pleomorphic' refers to how varied and irregular the cells look under the microscope. UPS (formerly called malignant fibrous histiocytoma) most often appears as a deep, painless, gradually enlarging mass in the thigh or another part of an arm or leg, though it can also occur in the trunk, the abdomen, or, sometimes, in skin damaged by previous radiation. Because it can grow quietly and painlessly for a while, any soft-tissue lump that is deep, larger than a few centimeters, or growing should be evaluated and biopsied rather than assumed to be harmless. UPS is generally a high-grade cancer, meaning its cells are aggressive and it can grow and spread relatively quickly; when it spreads, it travels most often to the lungs. The defining challenge in treating it is that, like other soft-tissue sarcomas, it pushes microscopic fingers of tumor into the surrounding tissue well beyond the firm visible mass — which is exactly why treatment pairs surgery with radiation. The modern goal is to cure the cancer while preserving the limb and its function: surgeons remove the tumor with a margin of healthy tissue, and radiation treats the wider area of microscopic disease so the limb can be kept and the chance of the cancer returning is reduced. Chemotherapy is considered in selected higher-risk situations and for disease that has spread.

How radiation treats it.

Radiation therapy treats undifferentiated pleomorphic sarcoma by delivering focused beams of energy that damage the DNA inside the tumor cells so they can no longer grow and divide. The reason radiation is such a standard partner to surgery here comes straight from how soft-tissue sarcomas grow: rather than staying neatly within the firm, visible mass, they push microscopic fingers of tumor into the surrounding muscle and connective tissue well beyond what can be seen or felt. If a surgeon removed only the visible tumor, those microscopic extensions could be left behind and seed a recurrence. Radiation solves this by treating a wider zone around the tumor, sterilizing the microscopic disease so the limb can be preserved and the cancer is far less likely to come back locally. There are two main ways to combine radiation with surgery. Given before surgery (preoperative), radiation uses a smaller treatment area and a lower dose and can make a limb-sparing operation safer and gentler on the limb's long-term function, though it requires extra attention to wound healing afterward. Given after surgery (postoperative), radiation treats the tumor bed using a larger area and a higher dose. Both approaches achieve excellent local control, and the choice is tailored to the tumor's size, location, and the surgical plan. Because the goal in the limb is to cure the cancer while keeping the limb working, modern techniques such as intensity-modulated radiation shape the dose tightly around the target to spare the surrounding muscle, bone, and joints. Radiation also has a role beyond the original site: when UPS spreads to a limited number of spots in the lungs, focused high-dose radiation (stereotactic body radiation) can ablate those deposits and provide durable control without surgery. In all of these settings, radiation's strength is treating disease that extends beyond, or has traveled past, the reach of the scalpel — which is precisely the challenge that this aggressive, infiltrating sarcoma presents.

The ways we can treat it.

Preoperative (neoadjuvant) radiation. Radiation given before surgery shrinks the margin of microscopic disease and uses a smaller treatment area and lower dose, which can make a limb-sparing operation safer and is associated with less long-term stiffness — at the cost of more wound-healing care.

Postoperative (adjuvant) radiation. Radiation to the tumor bed after surgery, used when preoperative radiation wasn't given, treats microscopic disease left behind and lowers the chance of local recurrence; it covers a larger area at a higher dose.

Intensity-modulated radiation (IMRT). Shaping the beams tightly around the target spares surrounding muscle, bone, and joints, helping preserve limb function while delivering a full dose to the tumor bed.

Stereotactic body radiation (SBRT) for metastases. Focused, high-dose radiation can ablate a limited number of lung metastases, offering durable control of oligometastatic disease without surgery.

Questions we hear often.

Will I lose my limb? Almost always, no. The modern standard for sarcomas in an arm or leg is limb-sparing treatment: the surgeon removes the tumor with a margin of healthy tissue, and radiation treats the wider area of microscopic disease so the limb can be kept. This approach controls the cancer as well as amputation did in the past, and the great majority of people keep a functional limb. Amputation is reserved for the uncommon tumor that can't be removed any other way.

Why do I need radiation if the surgeon removes the tumor? Because soft-tissue sarcomas like UPS send microscopic fingers of tumor into the surrounding tissue beyond the visible mass. Surgery removes the mass and a margin, but radiation treats the wider zone of microscopic disease that can't all be cut out without sacrificing the limb. Combining the two lets surgeons do a smaller, limb-preserving operation while keeping the chance of the cancer returning locally low. Radiation can be given before or after surgery, each with its own trade-offs.

Where does UPS spread, and how is that watched for? When undifferentiated pleomorphic sarcoma spreads, it travels through the bloodstream and most often goes to the lungs; spread to lymph nodes is uncommon. That's why a CT scan of the chest is part of the initial work-up and of follow-up. If a limited number of lung deposits appear, they can sometimes be removed surgically or treated with focused, high-dose radiation, and more widespread disease is treated with medication.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.